Basilar artery dissection treated by Neuroform stenting: fungal stent infection

Ratul Raychaudhuri1, Wengui Yu, Kimoo Hatanpaa

  • 1Department of Neurological Surgery, Univesity of Texas Southwestern Medical Center, Dallas, TX 75390-8855, USA.

Surgical Neurology
|March 4, 2008
PubMed
Abstract

Insights

Neuroform stenting for basilar artery dissection can cause complications like thromboembolism and fungal infection. Successful treatment of fungal stent infection with antifungal agents is demonstrated.

Area of Science:

  • Neurology
  • Interventional Neuroradiology

Background:

  • Basilar artery dissection is a serious condition.
  • Neuroform stenting is a potential treatment for basilar artery dissection, possibly safer than anticoagulation for patients with subarachnoid hemorrhage.
  • Potential complications of stenting include thromboembolism and infection.

Observation:

  • A 36-year-old male with basilar artery dissection underwent Neuroform stenting.
  • The patient developed bilateral pontine infarct and a fungal stent infection.
  • The patient had no history of immunocompromised status.

Findings:

  • Thromboembolism is a known complication of endovascular stenting.
  • Fungal stent infection is a significant concern, even in non-immunocompromised patients.
  • Successful treatment of fungal stent infection was achieved with parenteral antifungal agents.

Implications:

  • This case highlights potential pitfalls of Neuroform stenting for basilar artery dissection.
  • Further advancements in stent technology may reduce complications.
  • Novel antifungal agents show efficacy in treating stent infections.